In this excerpt from the webinar, “Pharmacovigilance Benefit-Risk Assessments: Requirements, Transparency, Implications” we help define Benefit-Risk Assessments and discuss the myriad of factors influencing the development of benefit-risk assessment frameworks. This excerpt is presented by Mary Mease, RPH, MPH, Senior Director of Benefit-Risk Management at Quintiles.

To see our full webinar, please click here.